A carregar...
ABT-263 Reduces Hypertrophic Scars by Targeting Apoptosis of Myofibroblasts
Background: Inhibiting proliferation and inducing apoptosis of myofibroblasts is becoming one of the promising and effective ways to treat hypertrophic scar. ABT-263, as an orally bioavailable BCL-2 family inhibitor, has showed great antitumor characteristics by targeting tumor cell apoptosis. The o...
Na minha lista:
| Publicado no: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7840494/ https://ncbi.nlm.nih.gov/pubmed/33519480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.615505 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|